All In Biotech

Drug Trial Radar · NCT02998840

A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure

A Prospective, Vehicle Controlled, Double Blinded, Multicenter, Randomized, Phase II Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure

Last checked: Nov 19, 2026Latest source record: Sep 15, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 132 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

132

Actual

Start

Nov 2016

Primary completion

Apr 25, 2017

Study completion Jun 26, 2017

Sponsor

Lead sponsor
AOBiome LLCIndustry
Sponsor type
Industry
Collaborators
Veristat, Inc.
First posted
Dec 21, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate and compare the efficacy of B244 in treating patients with hypertension.

Conditions

  • Prehypertension
  • Hypertension, Stage I

Interventions

  • B244Biological

    odorless suspension

  • VehicleBiological

    odorless suspension

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment-related Adverse Events as Assessed by CTCAE v4.0Time frame: Baseline-6 weeks
  2. Difference in Mean in Clinic Systolic BP Between the Active and Vehicle GroupsTime frame: Baseline-Week 4

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Central Research Associates

    Birmingham, Alabama

  • Elite Clinical Studies

    Phoenix, Arizona

  • Orange County Research Center

    Tustin, California

  • Clinical Research Consulting

    Milford, Connecticut

  • AGA Clinical Trials

    Hialeah, Florida

  • ICCT Research International

    Chicago, Illinois

  • MedPharmics

    Metairie, Louisiana

  • Alternative Primary Care (Einstein Clinical Research)

    Silver Spring, Maryland

  • CHEAR Center

    The Bronx, New York

  • Research Trials WorldWide

    Humble, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.